GetTopicDetailResponse(id=ad85e85255a, topicName=經鼻高流量氧療, introduction=經鼻高流量氧療, content=null, image=null, comments=2, allHits=1743, url=https://h5.medsci.cn/topic?id=78525, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=100102, tagList=[TagDto(tagId=100102, tagName=經鼻高流量氧療)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2209111, encodeId=2f2b22091116c, content=<a href='/topic/show?id=ca7856346b7' target=_blank style='color:#2F92EE;'>#持續(xù)氣道正壓通氣#</a> <a href='/topic/show?id=dba6e776367' target=_blank style='color:#2F92EE;'>#細支氣管炎#</a> <a href='/topic/show?id=ad85e85255a' target=_blank style='color:#2F92EE;'>#經鼻高流量氧療#</a>, objectTitle=PCCM：經鼻高流量氧療與氣泡式持續(xù)氣道正壓通氣治療中重度急性細支氣管炎的療效比較, objectType=article, longId=829254, objectId=05078292544f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717571472992_5579292.png, objectUrl=/article/show_article.do?id=05078292544f, replyNumber=0, likeNumber=130, createdTime=2024-06-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=05078292544f, moduleTitle=PCCM：經鼻高流量氧療與氣泡式持續(xù)氣道正壓通氣治療中重度急性細支氣管炎的療效比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=05078292544f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1487762, encodeId=67cd148e7621e, content=<a href='/topic/show?id=ad85e85255a' target=_blank style='color:#2F92EE;'>#經鼻高流量氧療#</a>, objectTitle=Lancet子刊：經鼻高流量氧療是否能降低免疫功能低下急性呼吸衰竭患者的死亡率？, objectType=article, longId=301846, objectId=e1b630184616, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1b630184616, replyNumber=0, likeNumber=136, createdTime=2022-03-30, rootId=0, userName=jklm12, userId=6f668361659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1b630184616, moduleTitle=Lancet子刊：經鼻高流量氧療是否能降低免疫功能低下急性呼吸衰竭患者的死亡率？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e1b630184616)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487761, encodeId=7e49148e761f0, content=<a href='/topic/show?id=ad85e85255a' target=_blank style='color:#2F92EE;'>#經鼻高流量氧療#</a>, objectTitle=新型冠狀病毒肺炎患者經鼻高流量氧療使用管理專家共識, objectType=article, longId=188976, objectId=63561889e639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63561889e639, replyNumber=0, likeNumber=96, createdTime=2020-03-01, rootId=0, userName=jklm12, userId=6f668361659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63561889e639, moduleTitle=新型冠狀病毒肺炎患者經鼻高流量氧療使用管理專家共識, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=63561889e639)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
